• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Breaking immunological tolerance to canine malignant melanoma using anti-Gpnmb antibody and various antigen peptides associated with tumor.

Research Project

Project/Area Number 23780317
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Clinical veterinary science
Research InstitutionObihiro University of Agriculture and Veterinary Medicine

Principal Investigator

TOMIHARI Mizuki  帯広畜産大学, 畜産学部, 助教 (00552754)

Project Period (FY) 2011 – 2012
Project Status Completed (Fiscal Year 2012)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2011: ¥2,340,000 (Direct Cost: ¥1,800,000、Indirect Cost: ¥540,000)
Keywords獣医学 / 臨床 / 癌 / 免疫学 / 生体分子 / 犬 / 悪性黒色腫 / 免疫療法 / 腫瘍
Research Abstract

We investigated new approachof immunological therapy for canine malignant melanoma, using anti-Gpnmb Ab and other various antigen peptides associated with tumor. The research showed that some peptides significantly activated T-lymphocytes compared to conventional method. However, the experiments with anti-Gpnmb Ab did not show notable results in T-cell activation. In the future research, we will thoroughly examine experimental conditions and intend to find more effective immunotherapy.

Report

(3 results)
  • 2012 Annual Research Report   Final Research Report ( PDF )
  • 2011 Research-status Report
  • Research Products

    (3 results)

All 2013 Other

All Journal Article (2 results) (of which Peer Reviewed: 1 results) Presentation (1 results)

  • [Journal Article] The DC-HIL ligand syndecan-4 is a negative regulator of T-cell allo-reactivity responsible for graft-versus-host disease.2013

    • Author(s)
      Chung JS, Tomihari M, Tamura K, Kojima T, Cruz PD Jr., Ariizumi K.
    • Journal Title

      Immunology

      Volume: 138(2) Pages: 173-82

    • Related Report
      2012 Final Research Report
  • [Journal Article] The DC-HIL ligand syndecan-4 is a negative regulator of T-cell allo-reactivity responsible for graft-versus-host disease.2013

    • Author(s)
      Chung JS, Tomihari M, Tamura K, Kojima T, Cruz PD Jr, Ariizumi K
    • Journal Title

      Immunology.

      Volume: 138(2) Issue: 2 Pages: 173-182

    • DOI

      10.1111/imm.12027

    • Related Report
      2012 Annual Research Report
    • Peer Reviewed
  • [Presentation] 活性化自己リンパ球療法を行った平滑筋肉腫の犬の1症例

    • Author(s)
      ○富張瑞樹、 東野 崇、 三重慧一郎、 三好雅史、 宮原和郎、 嶋田照雅
    • Organizer
      平成23年度北海道獣医学術学会北海道地区学会・北海道獣医師大会
    • Place of Presentation
      北海道大学
    • Related Report
      2011 Research-status Report

URL: 

Published: 2011-08-05   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi